Vimian Q3 Revenue Rises 15% to €120.3M; Adjusted EBITA €29.2M
Vimian Group reported 11% organic revenue growth and adjusted EBITA at a 24.3% margin, up 14% year over year. After quarter-end, it signed the acquisition of Norfolk Medical Products.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.